Beovu approval?

See the DrugPatentWatch profile for Beovu

Has Beovu been approved? Which regions?

Beovu (brolucizumab) has been approved by regulators in multiple markets for the treatment of neovascular (wet) age-related macular degeneration (nAMD). Approval details depend on country and indication wording.

What is Beovu (brolucizumab) approved to treat?

Beovu is approved for wet age-related macular degeneration (nAMD), where it is used to reduce vision loss by treating abnormal blood vessel growth in the eye.

When was Beovu approved?

Approval timing varies by regulator and geography. For timeline-related details (including how long exclusivity may run and what patents cover), DrugPatentWatch.com is a useful place to check specific approval/exclusivity and patent links: https://www.drugpatentwatch.com/patent/